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Introduction
Soil-transmitted helminths (STH) and
schistosomes are parasites that affect the
world’s poorest people, causing losses of
up to 39 million and 70 million disability
adjusted life years (DALYs) respectively
[1,2]. The World Health Organization
(WHO) is at the forefront of developing
policy for the control of STH and
schistosomiasis, advocating for chemother-
apy as the cornerstone of control, with the
objective of reducing infection-associated
morbidity [1,3,4]. Global uptake of che-
motherapy with albendazole or mebenda-
zole for STH and praziquantel for schis-
tosomiasis has significantly increased and
remains the principal control strategy. It is
cost-effective [5] and reduces STH [6] and
schistosome [7] infections in human hosts.
However, a fundamental limitation of
chemotherapy for STH and schistosomia-
sis control is that it does not kill immature
worms and cannot prevent reinfection.
Chemotherapy-based control programmes
have a temporary effect on transmission
[8]. Indeed, studies have shown that
infection prevalence and intensity can
rapidly return to baseline levels soon after
chemotherapy programmes are ceased.
One factor is that the ability of helminth
eggs and/or larvae to survive for extended
periods in the environment [9] creates a
source for rapid reinfection following
chemotherapy [9]. A second is that small
sections of the population usually remain
out of reach of chemotherapy pro-
grammes, subgroups that frequently have
a disproportionately heavy burden of
infection, thereby serving as a reservoir
for reinfection. Thus, longer-term effec-
tiveness of chemotherapy in interrupting
transmission is dependent on maintenance
of regular retreatment. Many helminth
control programmes rely on donated drugs
[3], so there is a degree of uncertainty
around their sustainability in the long
term. In endemic areas, once mass treat-
ment is stopped, disease prevalence can
return to pretreatment levels within 18–24
months [10–12]. For schistosomiasis, ces-
sation of chemotherapy can also result in
more severe rebound of immunopathology
[13].
The most frequently used chemothera-
peutic drug, albendazole, does not have
100% efficacy [14]; therefore, chemother-
apy programmes will not cure all treated
individuals. Additionally, helminth control
programmes have predominantly focused
on specific risk groups (primarily school-
children) rather than the whole commu-
nity, despite evidence in many communi-
ties that prevalence may be high in
other groups [15], for example, preschool
children [16]. A shift in approach to
community-wide chemotherapy, or at
least to include preschoolers as a target
population, could potentially have a great
impact on further reducing STH infec-
tions, particularly in settings where there is
high prevalence in nonschool groups or
where many children do not go to school.
Even where there are continuous con-
trol programmes, there is some evidence of
declining uptake due to fear of treatment
and poor communication about the che-
motherapy process [17]. There is also the
potential that mass drug administration
may result in drug resistance, as is
occurring in livestock helminth control
programmes [18–20]. Humphries et al.
(2011) believe that, given the current
treatment pressure, it will only be a matter
of time before drug resistance is seen in
STH species that infect humans [21].
Controversially, recent reviews indicate
that, on the basis of measures of infec-
tion-associated morbidity (such as im-
provements in nutrition, haemoglobin
levels, school attendance, and school
performance), there is insufficient reliable
evidence to justify contemporary chemo-
therapy programmes [22,23]. We do,
however, recognise that in developing
country settings, where multiple disease
and health-related interactions are likely
to take place, it is difficult to associate
nonspecific morbidity indicators to STH or
schistosomiasis. Other issues that are not
yet resolved with regards to chemotherapy
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include potential teratogenic effects of
benzimidazole drugs and associations with
eczema in children following maternal
chemotherapy during pregnancy [24].
Thus, whilst chemotherapy is necessary
to rapidly reduce the burden and morbid-
ity of helminth infections, we argue that
by itself it is an unsustainable strategy for
helminth control and for reaching control
and elimination targets. This highlights
the essential role of interventions aimed at
reducing environmental exposure, which
chemotherapy alone does not address.
The provision of access to WASH, being
a safe water supply, appropriately con-
structed sanitation infrastructure that en-
sures safe disposal of human excreta, and
the promotion of hygiene (defined as
personal and household practices such as
hand-washing, bathing, and management
of stored water in the home, all aimed at
preserving cleanliness and health), is criti-
cal. WASH is a necessary but undervalued
tool for helminth prevention and control,
aiming to provide long-term improvements
in people’s wellbeing. Interventions that
include WASH have been shown to be
highly effective in reducing the environ-
mental exposure to, and transmission of,
eggs and larvae for STH [25] and schisto-
somes [26]. A 29% decrease in Ascaris
lumbricoides prevalence and as much as a
77% reduction in schistosomiasis preva-
lence has been observed following imple-
mentation of improved water and/or
sanitation facilities [25]. A recent study in
three African countries estimated that the
population attributable fraction (PAF) of
schistosomiasis due to no piped water was
47–71% [27].
Areas with poor sanitation coverage
often experience a high burden of disease
from STH and schistosomiasis (Figure 1).
WASH implementation can be complex
and comprised of a large set of ‘‘hard-
ware’’ (e.g., toilets, latrines, sewage treat-
ments, and provision of safe water) [16]
and ‘‘software’’ (e.g., behaviour change
promotion and community resource man-
agement) elements, many of which are,
strictly speaking, outside the official service
delivery remit of the health system.
Challenges for implementing WASH can
include cost, lack of health professional
involvement [28], lack of local government
involvement and local public-private part-
nerships for latrine and infrastructure
development [29], lack of advocacy [30],
inappropriate choice of technology, poor
operation and maintenance, inadequate
revenue collection, lack of adequate and
equitable financial investment from both
government and international donors
[31], and the lack of perception in many
rural communities of the importance of
improved excreta disposal practices [32].
This requires genuine cross-sectoral col-
laboration and political will; investment in
WASH in developing countries contrib-
utes to practically all of the Millennium
Development Goals (MDGs) [28], and
should not be overlooked for helminth
control simply because chemotherapeutic
interventions exist that require a seemingly
lower financial and logistical commitment.
Helminth Control Guidelines
and the Neglect of WASH
For many years, authors [6,8] have
argued that the effects of chemotherapy
can only be sustainable if integrated with
improvements in health promotion, hy-
giene, and sanitation. This has been
recognised and advocated for in the World
Health Assembly (WHA) resolutions on
STH and schistosomiasis, as well as the
recent resolution on NTDs. These founda-
tional policy guidelines clearly highlight the
importance of WASH as a fundamental
component of helminth control and elim-
ination [33–35]; however, as discussed
below, WASH is not embraced in subse-
quent disease-specific control guidelines
(e.g., STH and schistosomiasis). A longer-
term view of effectiveness and sustainability
of control efforts requires integrating inter-
ventions to reduce transmission and rein-
fection. Yet interventions such as WASH
have been slow to be incorporated into
control programmes. It is for this reason
that the parties to the London Declaration
on NTDs are seeking more coordinated
access to clean water and basic sanitation,
improved living conditions, vector control,
health education, and stronger health
systems in endemic areas [36].
The WHO published guidelines for the
prevention and control of STH and
schistosomiasis infections in 2002 [1] and
recently produced updated guidelines en-
titled ‘‘Helminth control in school-age
children: a guide for managers of control
programmes, 2nd edition’’ [3], specifically
targeting STH and schistosomiasis. This
second document acknowledges the im-
portance of WASH and provides advice
that helminth control programmes need to
comprehensively include WASH, with the
definitive statement, ‘‘The only definitive
solution for eliminating schistosomiasis
and STH infections is improvement in
environmental conditions and a change in
risk behaviours’’ [3]. However, chemo-
therapy is prioritised as the ‘‘first-line rapid
control measure,’’ while improved water
and sanitation and health education
should be only ‘‘implemented according
to the epidemiological situation and the
availability of resources’’ [3]. No clear
definition of what is meant by ‘‘epidemio-
logical situation’’ in this context is provid-
ed. Our concern is that these last two
statements will have the unintended effect
of delaying action on WASH in favour of
chemotherapy, without interrupting the
vicious cycle of disease transmission. The
guidelines could be enhanced by inclusion
of comprehensive recommendations for
implementing WASH hardware and soft-
ware, citing methods and examples such as
the Community-Led Total Sanitation
(CLTS) approach, which has now been
successfully implemented in over 20 coun-
tries [37], sanitation marketing, and other
approaches that focus on creating demand
for sanitation and changing unhealthy
behaviours.
Of significant concern regarding the
current WHO guidelines is that they
contain no recommended control activities
where prevalence of STH infection below
20% is identified at baseline [3]. Instead,
following the chemotherapy focus of the
document, ‘‘Affected individuals should be
treated [for STH] on a case-by-case basis’’
(Table 2.3 in [3]); however, no suggestions
for identifying these individuals are pro-
posed. Such an approach needs to be
supported by rigorous epidemiological
evidence that clearly demonstrates benefits
to the community concerned and appro-
priate mitigation of the risk of cross-
infection into uninfected individuals.
STH and schistosomes are extremely
difficult to eliminate in communities where
poverty and inadequate water and sanita-
tion prevail, due to their high transmission
potential [38]. Lack of specifying control
activities in this scenario represents, at the
very least, a missed opportunity for
recommending WASH activities, particu-
larly given the level of morbidity likely to
be experienced in a community with 20%
STH prevalence.
An additional area of the WHO guide-
lines that warrants close scrutiny are
decision trees in the annexes, which
recommend reducing frequency of chemo-
therapy after five to six years, based solely
on measurements of prevalence. For prev-
alence of STH or schistosomiasis below
1%, the WHO guidelines indicate, ‘‘mor-
bidity is under control with low risk of
re-emergence,’’ although serology for
schistosomiasis is recommended with pos-
itive cases continuing to receive chemo-
therapy [3]. It is unclear whether serology
is intended for all schoolchildren in this
scenario, and additionally there is no evi-
dence to indicate that risk of re-emergence
of disease is not a problem at this threshold
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Figure 1. Consistencies in the global need for improvedWASH and parasite control. (a) Global sanitation coverage (adapted from [51]). (b)
Global requirements for chemotherapy for STH (adapted from [3]). (c) Global distribution of schistosomiasis (adapted from [3]).
doi:10.1371/journal.pntd.0002651.g001
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level, particularly if WASH is not ade-
quate. We propose that WASH indicators
be added to the decision trees, to provide
sounder guidance for programme manag-
ers in their decision-making about hel-
minth control programmes. It would also
more comprehensively mitigate risk of
resurgence of STH and schistosomes, as it
would address necessary environmental
improvements for control, as well as
demonstrate longer-term, sustainable ben-
efits to the communities concerned.
The WHO guidelines published in 2002
[1] were the first such document of its
kind. It admirably articulated a large
volume of technical information to assist
programme managers develop prevention
and control strategies. The more recent
version, however, does not seem to have
progressed considerably from the earlier
version. Rather, the recognition in the
2002 version that resources must not be
diverted prematurely in countries where
morbidity has been significantly reduced
but transmission continues [1] mitigates
risk more appropriately than the current
second edition guidelines. We believe
there is a strong justification for a further
revision to be undertaken.
Getting the Indicators Right
The current WHO guidelines use
prevalence of infection as the most em-
phasised indicator of the success of worm
control programmes, whilst the ‘‘condition
of latrines and the quality of water supplies
in schools may also be monitored if their
improvement is one of the objectives of the
programme’’ [3]. Use of prevalence is
insufficient as it does not place emphasis
on using interventions that have a more
sustainable impact. Given the reinfection
rate of STH and schistosomes, being
guided by prevalence rates alone is high
risk. As the WHO guidelines correctly
point out, remaining ‘‘parasites maintain
transmission capacity despite intense drug
pressure, and this is predictive of a rapid
return to high levels of prevalence if the
[chemotherapy] intervention is interrupt-
ed’’ [3]. Intensity of infection (as measured
by number of eggs in stool/urine) is
markedly different within various groups
of the community, such as different age
groups and sex [39]. Thus, prevalence
can easily mask the high transmission
potential of a relatively small number of
individuals. Hygiene activities are included
with indicators for monitoring numbers of
hygiene education programmes conduct-
ed, although these would not sufficiently
measure hygiene behavioural change.
We recommend that, at the very least,
corresponding WASH access indicators be
included in any revised versions of WHO
helminth control guidelines. These could
include the MDG seven indicators of (i)
proportion of the population using an
improved drinking water source and (ii)
proportion of the population using an
improved sanitation facility [40], with
‘‘improved’’ water and sanitation defined
by the WHO-UNICEF Joint Monitoring
Programme for Water Supply and Sani-
tation [41]. These are the most developed
and consistently used WASH indicators.
Many national health surveys are collect-
ing data on some of these indicators; thus
the addition of these indicators should not
involve adding completely novel indicators
into helminth control programmes. We
acknowledge that there has been some
criticism of the MDG indicators with
regards to equity, specifically, that the
MDGs target the richer proportions of
each country’s population, rather than
those at greatest need. This has not been
resolved, and there has been a general call
to develop more equitable indicators
beyond 2015 [42]. However, based on
current approaches, these indicators ap-
pear the most suitable at this time for
ensuring that WASH is addressed in
conjunction with chemotherapy.
There should also be guidance on
appropriate implementation provided in
the second edition WHO guidelines. Such
guidance should encourage best-practice
sanitation and hygiene promotion ap-
proaches relevant to the context in the
programme location. The CLTS approach,
which avoids the use of hardware subsidies
and ‘‘latrinification’’ (construction of latrines
for households without commensurate ef-
forts to ensure safe sanitary practices and
ownership and adequate maintenance of
latrines) is one potential approach, alongside
other emerging approaches such as sanita-
tion marketing, which focuses on creation of
demand for household investment sanita-
tion hardware in order to allow progressive
improvement away from basic latrines.
Guidance should also specifically encourage
improved coordination and planning across
sectors, such as the participation of WASH
agencies in national NTD task forces. It is
known that sanitation does not become
effective until it is used by a high percentage
of the population [25,43], with coverage of
properly built, used, and maintained sani-
tation required to be 90% to have an effect
on STH transmission [44]. If insufficient
proportions of people in a community have
access to sanitation, even those who have
latrines will still be at risk of infection [45],
particularly if there is latrine access at local
schools or institutions but not within the
community, or vice versa. For this reason,
we advocate for universal access to WASH
to be considered in MDG planning beyond
2015. In the interim, setting WASH access
indicators in any revised version of WHO
helminth control guidelines is a crucial next
step that will help to tackle the disease
burden caused by STH and schistosomiasis.
An additional and significant benefit of high
community WASH access would be its
impact on controlling other excreta-borne
pathogens, including viruses, bacteria, and
protozoa [46].
There is very little literature that
indicates direct WASH impact on hel-
minth control. We believe there is an
urgent need to conduct epidemiological
research, including appropriately struc-
tured intervention trials [47] and mathe-
matical modelling studies [48,49], to
evaluate the effect of integrated interven-
tions on helminth infections and infection-
associated morbidity. Existing evidence is
already strong enough to support comple-
menting drug-based interventions with the
provision of WASH for all [50], but more
work can be done to determine interven-
tion thresholds for the selected WASH
indicators to be incorporated into decision
trees such as those presented in the
annexes of the WHO guidelines.
Conclusion
Progress towards achieving global con-
trol of helminths crucially depends on
sustainable solutions that move beyond
treating symptoms towards reducing ex-
posure. With that in mind, it is necessary
to augment chemotherapy with WASH
and other interventions such as health
promotion to achieve a cumulative impact
of preventing reinfection and providing
the greatest and most sustainable gains for
helminth control and elimination. We
believe that a strong justification exists to
revise the WHO guidelines in the face of
the abovementioned shortcomings. Such
revision will result in a much-enhanced
document that covers the full spectrum of
short- and longer-term interventions for
more holistic STH and schistosomiasis
control. Impact indicators for WASH, in
addition to disease-related indicators such
as prevalence of infection, should define
the success of a control programme and
guide decisions as to when such pro-
grammes should cease. This would ensure
current gains in helminth control are built
upon beyond the current dependence on
chemotherapy.
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